Medifast Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 1995
Net Income	99.42	143.57	164.03	102.86	77.92	55.79	27.72	17.84	20.06	13.18	Upgrade
Depreciation & Amortization	17.71	17.08	11.88	7.51	7.25	4.44	4.21	5.41	7.12	8.05	Upgrade
Share-Based Compensation	8.19	11.05	9.9	6.8	4.52	3.12	4.27	3.43	3.08	3.92	Upgrade
Other Operating Activities	22.34	22.87	-91.27	28.04	-5.42	-2.53	7.04	-1.32	-0.84	0.39	Upgrade
Operating Cash Flow	147.66	194.57	94.55	145.2	84.26	60.82	43.24	25.35	29.41	25.54	Upgrade
Operating Cash Flow Growth	-24.11%	105.80%	-34.88%	72.32%	38.55%	40.66%	70.56%	-13.81%	15.17%	-39.72%	Upgrade
Capital Expenditures	-6.48	-16.68	-34.21	-5.89	-10.06	-4.74	-3.16	-2.2	-2.82	-7.02	Upgrade
Change in Investments	-54.56	5.27	5.15	4.61	3.73	3.55	-0	0.16	2.63	3.56	Upgrade
Other Investing Activities	-	-	-	-	-	-	-	-	-	0.95	Upgrade
Investing Cash Flow	-61.05	-11.41	-29.06	-1.28	-6.33	-1.2	-3.16	-2.04	-0.19	-2.52	Upgrade
Dividends Paid	-73.02	-71.62	-63.86	-53.19	-35.4	-23.16	-15.39	-11.89	0	0	Upgrade
Share Issuance / Repurchase	-6.96	-127.96	-62.09	-5.55	-47.21	-30.72	-2.54	-1.34	-11.81	-35.05	Upgrade
Debt Issued / Paid	0	0	0	0	0	0	0	-0.22	-0.26	-0.22	Upgrade
Other Financing Activities	0.19	-	0.81	1.6	0.28	0.55	0.57	0.53	0.34	0.33	Upgrade
Financing Cash Flow	-79.79	-199.58	-125.13	-57.14	-82.32	-53.33	-17.36	-12.92	-11.73	-34.94	Upgrade
Exchange Rate Effect	-0.07	-0.07	0.11	-0.02	0	-0	-0.07	0.01	0.09	0	Upgrade
Net Cash Flow	6.75	-16.49	-59.54	86.75	-4.39	6.29	22.64	10.4	17.58	-11.92	Upgrade
Free Cash Flow	141.17	177.89	60.34	139.31	74.2	56.07	40.08	23.15	26.59	18.51	Upgrade
Free Cash Flow Growth	-20.64%	194.83%	-56.69%	87.74%	32.34%	39.91%	73.11%	-12.94%	43.65%	-40.23%	Upgrade
Free Cash Flow Margin	13.17%	11.13%	3.95%	14.90%	10.40%	11.19%	13.29%	8.43%	9.75%	6.49%	Upgrade
Free Cash Flow Per Share	12.97	15.89	5.16	11.84	6.30	4.69	3.36	1.96	2.22	1.46	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).